Shares of FMC Corporation (FMC.N) declined sharply today, hitting a 52-week low as investor sentiment waned following a series of analyst downgrades. The stock's technical status reflects increased bearish momentum, with the recent price action signaling a lack of confidence in the company's earnings outlook. Analysts have significantly lowered their price targets for FMC, citing disappointing sales and earnings guidance for FY2025, which has further pressured the stock.
In the context of rising investor interest in dividend-yielding stocks, FMC's high dividend yield of 18.11% has not been enough to offset concerns over its financial performance. The company is set to address these challenges at the upcoming Goldman Sachs Industrials and Materials Conference, where CEO Pierre Brondeau and CFO Andrew Sandifer will discuss the company's strategies and outlook on December 3, 2025. As FMC navigates these turbulent market conditions, investors will be closely monitoring any developments that could impact its recovery prospects.
Wall Street analysts forecast FMC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FMC is 19.08 USD with a low forecast of 13.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
Wall Street analysts forecast FMC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FMC is 19.08 USD with a low forecast of 13.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
10 Hold
1 Sell
Hold
Current: 16.020
Low
13.00
Averages
19.08
High
28.00
Current: 16.020
Low
13.00
Averages
19.08
High
28.00
RBC Capital
Arun Viswanathan
Sector Perform
downgrade
$17 -> $16
2026-01-21
Reason
RBC Capital
Arun Viswanathan
Price Target
$17 -> $16
AI Analysis
2026-01-21
downgrade
Sector Perform
Reason
RBC Capital analyst Arun Viswanathan lowered the firm's price target on FMC to $16 from $17 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q4 for Specialty Chemicals. The firm is expecting in-line prints for Q4 and continues to see company-specific items driving improvement in 2026, the analyst tells investors in a research note.
Citi
Patrick Cunningham
Neutral
maintain
$14 -> $16
2026-01-21
Reason
Citi
Patrick Cunningham
Price Target
$14 -> $16
2026-01-21
maintain
Neutral
Reason
Citi analyst Patrick Cunningham raised the firm's price target on FMC to $16 from $14 and keeps a Neutral rating on the shares. The firm adjusted targets in the specialty chemicals group as part of a Q4 preview. Citi sees a better currency and sales environment for the sector, but with the potential for "fresh tariff risks."
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FMC
Unlock Now
Mizuho
Outperform
downgrade
$24 -> $21
2026-01-16
Reason
Mizuho
Price Target
$24 -> $21
2026-01-16
downgrade
Outperform
Reason
Mizuho lowered the firm's price target on FMC to $21 from $24 and keeps an Outperform rating on the shares. The firm adjusted targets in the agriculture group as part of a quarterly earnings preview. Continued pressure on corn prices and the expectation that earnings will be lower in 2026 verses 2025 for most fertilizer companies make Mizuho "reluctant to be more constructive on fertilizers," the analyst tells investors in a research note.
BofA
Neutral
downgrade
$18 -> $17
2026-01-08
Reason
BofA
Price Target
$18 -> $17
2026-01-08
downgrade
Neutral
Reason
BofA lowered the firm's price target on FMC to $17 from $18 and keeps a Neutral rating on the shares. The firm is updating its price targets for Chemicals under its coverage, the analyst tells investors. Commodities face another year of growing oversupply, specialties continue to manage an inconsistent backdrop, and agriculture presents a more mixed setup, the firm adds. BofA highlights that there are areas for optimism, with several possible catalysts for the stocks including PMI indicators shifting positive, rate cuts, and potential capacity rationalization in China. The firm cautions, however, that these catalysts are too new to rely on.
About FMC
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
